[Fascinated by pulmonary function].

Masayuki Kambe

Home/Archive/PubMed

PubMed · 15027319

[Fascinated by pulmonary function].

Masayuki Kambe

View original source ↗Export metadata ↓

Abstract

I would like to tell you about my 35 years of research, starting when I became a medical doctor, titled "Fascinated by Pulmonary Function". For the first 10 years, I studied the automation of pulmonary function tests and developed some automatic pulmonary function test apparatuses such as the spiro-computer, panspiro-computer, automatic respiratory resistant test apparatus and automatic respiratory central function test apparatus. For the next 15 years, I studied the relationships between some important pulmonary diseases and respiratory pulmonary functions. In particular, I studied respiratory efficiency and respiratory center functions. For the most recent 10 years, I have been studying the relationships between non-respiratory pulmonary functions and chronic respiratory diseases. I am studying the relationships between ATP(Adenosine Tri Phosphate) in the blood for the parameters of mitochondria function and pneumoconiosis and other chronic pulmonary diseases. I had very interesting results regarding DNA types of arteriosclerosis in chronic pulmonary emphysema. I thank all my research fellows during these 35 years from the bottom of my heart.

Explore related subjects

Adenosine Triphosphate History, 20th Century History, 21st Century Humans Japan Pulmonary Medicine Respiration Respiratory Center Respiratory Function Tests Biography English Abstract Historical Article Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Masayuki Kambe. 2004. [Fascinated by pulmonary function].. https://pubmed.ncbi.nlm.nih.gov/15027319/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The human mitochondrial genome contains a second light strand promoter.

The human mitochondrial genome must be replicated and expressed in a timely manner to maintain energy metabolism and supply cells with adequate levels of adenosine triphosphate. Central to this process is the idea that replication primers and gene products both arise via transcription from a single light strand promoter (LSP) such that primer formation can influence gene expression, with no consensus as to how this is regulated. Here, we report the discovery of a second light strand promoter (LSP2) in humans, with features characteristic of a bona fide mitochondrial promoter. We propose that the position of LSP2 on the mitochondrial genome allows replication and gene expression to be orchestrated from two distinct sites, which expands our long-held understanding of mitochondrial gene expression in humans.

Adenosine Triphosphate↗

PubMed2021

GCN2 kinase activation by ATP-competitive kinase inhibitors.

Small-molecule kinase inhibitors represent a major group of cancer therapeutics, but tumor responses are often incomplete. To identify pathways that modulate kinase inhibitor response, we conducted a genome-wide knockout (KO) screen in glioblastoma cells treated with the pan-ErbB inhibitor neratinib. Loss of general control nonderepressible 2 (GCN2) kinase rendered cells resistant to neratinib, whereas depletion of the GADD34 phosphatase increased neratinib sensitivity. Loss of GCN2 conferred neratinib resistance by preventing binding and activation of GCN2 by neratinib. Several other Food and Drug Administration (FDA)-approved inhibitors, such erlotinib and sunitinib, also bound and activated GCN2. Our results highlight the utility of genome-wide functional screens to uncover novel mechanisms of drug action and document the role of the integrated stress response (ISR) in modulating the response to inhibitors of oncogenic kinases.

Adenosine Triphosphate↗

PubMed2007

Inhibition of insulin secretion by cerulenin might be due to impaired glucose metabolism.

BACKGROUND: Cerulenin, an inhibitor of protein acylation, has been used as a tool to study the potential role of protein acylation in a variety of activities in different cells, and in stimulus-secretion coupling in pancreatic islets and clonal beta-cells. METHODS: In the present study we investigated its effects on stimulated insulin secretion, glucose metabolism and utilization, oxygen consumption and ATP levels. RESULTS: In isolated rat pancreatic islets, cerulenin pre-treatment (100 microM) inhibited insulin secretion in response to glucose, and to the non-hydrolysable analogue of leucine, aminobicyclo-[2,2,1]heptane-2-carboxylic acid (BCH). These data are in accord with the hypothesis that protein acylation could be involved in the stimulation of insulin secretion. However, we also found that cerulenin profoundly decreased glucose oxidation, glucose utilization, oxygen consumption and ATP levels. Consequently, decreased metabolism provides an alternative mechanism to inhibition of protein acylation that could explain the inhibition of insulin secretion by cerulenin. CONCLUSIONS: Inhibition of insulin secretion by cerulenin can no longer be taken as evidence in favour of a role for protein acylation in the control of insulin release. As protein acylation is known to be involved in the normal functioning of proteins in stimulus-secretion coupling and exocytosis, more direct approaches to understand its role(s) are required.

Adenosine Triphosphate↗